Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-01-15 @ 7:09 PM
Study NCT ID:
NCT03366103
Status:
TERMINATED
Last Update Posted:
2023-10-17
First Post:
2017-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-07
First Submit QC Date:
None
Study First Post Date:
2017-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-30
Results First Submit QC Date:
None
Results First Post Date:
2023-05-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-22
Last Update Post Date:
2023-10-17
Last Update Post Date Type:
ACTUAL